SUBSCRIBERS
Gilead wins reversal of US$2.54b hepatitis C drug patent verdict
Published Sun, Feb 18, 2018 · 09:50 PM
Boston
A US federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record US$2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by rival Merck & Co Inc.
The verdict had been the largest ever in a US patent case but US District Judge Leonard Stark in W…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Cordlife customers push for legal action
China knockoff raid jolts a global throng of fake-fashion influencers
Apparel company Express seeks quick bankruptcy sale
Mattel posts narrower loss, thanks to Hot Wheels growth and lower costs
Starbucks set for talks with unionised US stores
Gucci-owner Kering posts 10% drop in Q1 sales on sluggish Chinese demand